J. P. Lalezari Et Al. , "Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV," 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , vol.60, Massachusetts, United States Of America, 2014
Lalezari, J. P. Et Al. 2014. Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV. 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , (Massachusetts, United States Of America).
Lalezari, J. P., Pruitt, R., Luo, Y., Aspinall, R. J., Gaeta, G. B., Olszok, I., ... King, W.(2014). Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV . 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America
Lalezari, Jacob Et Al. "Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV," 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 2014
Lalezari, Jacob P. Et Al. "Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV." 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , Massachusetts, United States Of America, 2014
Lalezari, J. P. Et Al. (2014) . "Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV." 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , Massachusetts, United States Of America.
@conferencepaper{conferencepaper, author={Jacob P. Lalezari Et Al. }, title={Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV}, congress name={65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases}, city={Massachusetts}, country={United States Of America}, year={2014}}